SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Devauchelle V)
 

Sökning: WFRF:(Devauchelle V) > Systemic manifestat...

Systemic manifestations of primary Sjogren's syndrome out of the ESSDAI classification : prevalence and clinical relevance in a large international, multi-ethnic cohort of patients

Retamozo, S. (författare)
UNC, Consejo Nacl Invest Cient & Tecn CONICET, Inst Invest Ciencias Salud INICSA, Cordoba, Argentina;IUCBC, Cordoba, Argentina
Acar-Denizli, N. (författare)
Mimar Sinant Fine Arts Univ, Fac Sci & Letters, Dept Stat, Istanbul, Turkey
Rasmussen, A. (författare)
Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Programme, 825 NE 13th St, Oklahoma City, OK 73104 USA
visa fler...
Horvath, I. F. (författare)
Univ Debrecen, Fac Med, Div Clin Immunol, Debrecen, Hungary
Baldini, C. (författare)
Univ Pisa, Rheumatol Unit, Pisa, Italy
Priori, R. (författare)
Sapienza Univ Rome, Rheumatol Clin, Dept Internal Med & Med Specialties, Rome, Italy
Sandhya, P. (författare)
Christian Med Coll & Hosp, Dept Clin Immunol & Rheumatol, Vellore, Tamil Nadu, India
Hernandez-Molina, G. (författare)
Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Immunol & Rheumatol Dept, Mexico City, DF, Mexico
Armagan, B. (författare)
Hacettepe Univ, Fac Med, Dept Internal Med, Ankara, Turkey
Praprotnik, S. (författare)
Univ Med Ctr, Dept Rheumatol, Ljubljana, Slovenia
Kvarnstrom, M. (författare)
Karolinska Institutet
Gerli, R. (författare)
Univ Perugia, Dept Med, Rheumatol Unit, Perugia, Italy
Sebastian, A. (författare)
Wroclaw Med Univ, Dept Rheumatol & Internal Med, Wroclaw, Poland
Solans, R. (författare)
Hosp Valle De Hebron, Dept Internal Med, Barcelona, Spain
Rischmueller, M. (författare)
Queen Elizabeth Hosp, Dept Rheumatol, Adelaide, SA, Australia;Univ Adelaide, Adelaide, SA, Australia
Pasoto, S. G. (författare)
Univ Sao Paulo, Fac Med, HCFMUSP, Hosp Clin,Rheumatol Div, Sao Paulo, Brazil
Valim, V. (författare)
Univ Fed Espirito Santo, Dept Med, Vitoria, ES, Brazil
Nordmark, Gunnel (författare)
Uppsala universitet,Reumatologi
Kruize, A. A. (författare)
Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands
Nakamura, H. (författare)
Nagasaki Univ, Grad Sch Biomed Sci, Div Adv Prevent Med Sci, Dept Immunol & Rheumatol, Nagasaka, Yamanashi, Japan
Hofauer, B. (författare)
Univ Freiburg, Otorhinolaryngol Head & Neck Surg, Freiburg, Germany
Giacomelli, R. (författare)
Univ Aquila, Sch Med, Clin Unit Rheumatol, Laquila, Italy
Fernandes Moca Trevisani, V. (författare)
Univ Fed Sao Paulo, Sao Paulo, Brazil
Devauchelle-Pensec, V. (författare)
Brest Univ Hosp, Rheumatol Dept, Paris, France
Atzeni, F. (författare)
Univ Messina, Inst Milan, IRCCS Galeazzi Orthopaed, Messina, Italy;Univ Messina, Rheumatol Unit, Messina, Italy
Gheita, T. A. (författare)
Cairo Univ, Kasr Al Amny Sch Med, Rheumatol Dept, Cairo, Egypt
Consani-Fernandez, S. (författare)
Hosp Maciel, Internal Med, Montevideo, Uruguay;Univ Republ UdelaR, Montevideo, Uruguay
Szanto, A. (författare)
Univ Debrecen, Fac Med, Div Clin Immunol, Debrecen, Hungary
Sivils, K. (författare)
Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Programme, 825 NE 13th St, Oklahoma City, OK 73104 USA
Gattamelata, A. (författare)
Sapienza Univ Rome, Rheumatol Clin, Dept Internal Med & Med Specialties, Rome, Italy
Danda, D. (författare)
Christian Med Coll & Hosp, Dept Clin Immunol & Rheumatol, Vellore, Tamil Nadu, India
Kilic, L. (författare)
Hacettepe Univ, Fac Med, Dept Internal Med, Ankara, Turkey
Bartoloni, E. (författare)
Bombardieri, S. (författare)
Sanchez-Guerrero, J. (författare)
Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Immunol & Rheumatol Dept, Mexico City, DF, Mexico
Wahren-Herlenius, M. (författare)
Karolinska Institutet
Mariette, X. (författare)
Univ Paris Sud, Ctr Immunol Viral Infect & Autoimmune Dis, Hop Univ Paris Sud, AP HP,UMR1184,INSERM, Paris, France
Ramos-Casals, M. (författare)
Univ Barcelona, Sjogrens Syndrome Res Grp AGAUR, Lab Autoimmune Dis Josep Font,Hosp Clin, IDIBAPS CELLEX,Dept Autoimmune Dis ICMiD, Barcelona, Spain
Brito-Zeron, P. (författare)
Univ Barcelona, Sjogrens Syndrome Res Grp AGAUR, Lab Autoimmune Dis Josep Font,Hosp Clin, IDIBAPS CELLEX,Dept Autoimmune Dis ICMiD, Barcelona, Spain;Hosp CIMA Sanitas, Dept Med, Autoinmmne Dis Unit, Barcelona, Spain
Nakamura, T (författare)
visa färre...
 (creator_code:org_t)
CLINICAL & EXPER RHEUMATOLOGY, 2019
2019
Engelska.
Ingår i: Clinical and Experimental Rheumatology. - : CLINICAL & EXPER RHEUMATOLOGY. - 0392-856X .- 1593-098X. ; 71
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Objectives: To analyse the frequency and characterise the systemic presentation of primary Sjogren's syndrome (SS) out of the ESSDAI classification in a large international, multi-ethnic cohort of patients. Methods: The Big Data Sjogren Project Consortium is an international, multicentre registry based on world-wide data-sharing and cooperative merging of pre-existing clinical SS databases from leading centres in clinical research in SS from the five continents. A list of 26 organ-by-organ systemic features not currently included in the ESSDAI classification was defined according to previous studies; these features were retrospectively recorded. Results: Information about non-ESSDAI features was available in 6331 patients [5,917 female, mean age at diagnosis 52 years, mainly White (86.3%)]. A total of 1641 (26%) patients had at least one of the ESSDAI systemic features. Cardiovascular manifestations were the most frequent organ-specific group of non-ESSDAI features reported in our patients (17% of the total cohort), with Raynaud's phenomenon being reported in 15%. Patients with systemic disease due to non-ESSDAI features had a lower frequency of dry mouth (90.7% vs. 94.1%, p<0.001) and positive minor salivary gland biopsy (86.7% vs. 89%, p=0.033), a higher frequency of anti-Ro/SSA (74.7% vs. 68.7%, p<0.001), anti-La/SSB antibodies (44.5% vs. 40.4%, p=0.004), ANA (82.7% vs. 79.5%, p=0.006), low C3 levels (17.4% vs. 9.7%, p<0.001), low C4 levels (14.4% vs. 9.6%, p<0.001), and positive serum cryoglobulins (8.6% vs. 5.5%, p=0.001). Systemic activity measured by the ESSDAI, clinESSDAI and DAS was higher in patients with systemic disease out of the ESSDAI in comparison with those without these features (p<0.001 for all comparisons). Conclusions: More than a quarter of patients with primary SS may have systemic manifestations not currently included in the ESSDAI classification, with a wide variety of cardiovascular, digestive, pulmonary, neurological, ocular, ENT (ear, nose, and throat), cutaneous and urological features that increase the scope of the systemic phenotype of the disease. However, the individual frequency of each of these non-ESSDAI features was very low, except for Raynaud's phenomenon.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Reumatologi och inflammation (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Rheumatology and Autoimmunity (hsv//eng)

Nyckelord

primary Sjogren's syndrome
ESSDAI
Raynaud's phenomenon
pleuritis
pericarditis
uveitis
congenital heart block
pulmonary arterial hypertension

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy